Name

MAZE

Alternate names

None

Primary Site

None

Histology

None

Radiation

None

Remarks

None

Drugs for MAZE

Name

Alternate Names

Dom-Etoposide
Epipodophyllotoxin derivative
Epipodophyllotoxin ethylidene gluco-pyranoside
Eposine
Ethylidene-Lignan P
Etopophos
Podophyllotoxin derivative
Vepesid
VP 16-213
VP-16
VP-16213
Toposar

Abbreviations

EPEG
VP-16
VP-16-213

Category

Chemotherapy

Subcategory

Epipodophyllotoxin, topoisomerase II inhibitor
Plant alkaloid

NSC Number

141540

Primary Site

Gastric cancer
Hodgkins lymphoma
Lung cancer (NSCLC, SCLC)
Non-Hodgkin lymphoma

Histology

None

Remarks

Plant alkaloid. FDA approved use on small-cell lung cancer, testicular cancer.

Coding

This drug should be coded

Name

Alternate Names

496
5-Azacitidine
5-Azacytidine
Antibiotic U-18
AZA-CR
Azacytidine
Ladakamycin
Mylosar
Vidaza

Abbreviations

5-AC
5-AZA
5-AZAC
5-AZCR
AZC

Category

Chemotherapy

Subcategory

Antimetabolite

NSC Number

102816

Primary Site

Leukemia

Histology

None

Remarks

Phase II/III MDS, Phase I AML Antineoplastic agent; reduction in size or spread of neoplasm; improvement in hematologic parameters;bone marrow aspirate; antimetabolite; also differentiation inducing agent. NCI

Coding

This drug should be coded
Glossary